Wallace studies mitochondria, tiny structures that serve as our cells’ “power plants,” converting food and oxygen into energy. Mitochondria are actually symbiotic bacteria that invaded our cells more than 2 billion years ago.
Monthly Archive: May 2013
For several years, the Teen Driver Safety Research team at the Center for Injury Research & Prevention (CIRP) at The Children’s Hospital of Philadelphia has strived to reduce the frequency and severity of teens’ motor vehicle crashes, injuries, and fatalities.
The failure to address the emotional and behavioral problems of school-age children can have serious, life-changing ramifications, including poor grades, suspension and expulsion, and problems with the law later in life.
A new grant award will allow an investigator at The Children’s Hospital of Philadelphia to study the effectiveness of certain drugs called retinoid agonists in slowing or preventing muscle degeneration in individuals with muscular dystrophy.
Struan Grant, PhD, associate director of The Children’s Hospital of Philadelphia’s Center for Applied Genomics (CAG), co-authored a study that discovered new loci associated with body mass index (BMI) in adults of African ancestry.
Stem cells have the unique ability to develop, or differentiate, into other kinds of cells in the body. Researchers have now manipulated human stem cells so that they produce the types of brain cells that play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia, and autism.
Kristy Arbogast, PhD, director of engineering at the Center for Injury Research and Prevention at CHOP, led the report, which reviewed the current science and data regarding rear seat occupant safety.
Researchers from The Children’s Hospital of Philadelphia and the Perelman School of Medicine at The University of Pennsylvania, along with colleagues at the Botswana-Baylor Children’s Clinical Centre of Excellence, conducted the first large-scale comparison the two drugs, efavirenz and nevirapine.
A groundbreaking clinical trial of gene therapy for a form of congenital blindness, sponsored by The Children’s Hospital of Philadelphia in collaboration with Penn Medicine, was recently recognized with the Distinguished Clinical Research Achievement Award from the Clinical Research Forum, an organization of clinical research centers, industry, and volunteer groups.